Importance of the PaCO(2) from 3 to 6 months after initiation of long-term non-invasive ventilation

Respir Med. 2010 Dec;104(12):1850-7. doi: 10.1016/j.rmed.2010.04.027. Epub 2010 May 26.

Abstract

Background: The level at which arterial carbon dioxide tension (PaCO(2)) a few months after introduction of long-term non-invasive positive pressure ventilation (NPPV) is associated with a favorable prognosis remains uncertain.

Methods: Data on 184 post-tuberculosis patients with chronic restrictive ventilatory failure who were receiving long-term domiciliary NPPV were examined retrospectively. Average PaCO(2) 3-6 months after NPPV (3- to 6-mo PaCO(2)) and potential confounders were analyzed with discontinuation of long-term NPPV as the primary outcome. The effects of 3- to 6-mo PaCO(2) on annual hospitalization rates due to respiratory deterioration from 1 year before to 3 years after the initiation of NPPV were examined. The effect of the difference between the PaCO(2) value at the start of NPPV (0-mo PaCO(2)) and the PaCO(2) value 3- to 6-mo later (d-PaCO(2)) on continuation rates for NPPV was also assessed in patients who initiated NPPV while in a chronic state.

Results: Patients with relatively low 3- to 6-mo PaCO(2) values maintained a relatively low PaCO(2) 6-36 months after NPPV (p < 0.0001) and had significantly better continuation rates (p < 0.03) and lower hospitalization rates from the 1st to 3rd year of NPPV (p = 0.008, 0.049, 0.009, respectively) than those with higher levels. The 0-mo PaCO(2) (p = 0.26) or d-PaCO(2) (p = 0.86) had no predictive value.

Conclusion: A relatively low 3- to 6-mo PaCO(2) value was predictive of long-term use of NPPV. The target values for 3- to 6-mo PaCO(2) may, therefore, be less than 60 mmHg in post-tuberculosis patients, although more studies are needed.

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • Blood Gas Analysis
  • Carbon Dioxide / blood*
  • Chronic Disease
  • Female
  • Home Care Services, Hospital-Based / standards
  • Hospitalization / statistics & numerical data
  • Humans
  • Male
  • Positive-Pressure Respiration / methods*
  • Prognosis
  • Respiratory Function Tests
  • Respiratory Insufficiency / blood*
  • Respiratory Insufficiency / physiopathology
  • Respiratory Insufficiency / therapy
  • Retrospective Studies
  • Time Factors
  • Tuberculosis, Pulmonary / blood*
  • Tuberculosis, Pulmonary / physiopathology
  • Tuberculosis, Pulmonary / therapy

Substances

  • Carbon Dioxide